SCHEMBL1404979

SCHEMBL1404979

CC(=O)CCc1ccccc1NC(C)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
LMNA P02545 2/20 0.54
MAPK1 P28482 1/20 0.53
HPGD P15428 1/20 0.52
IAPP P10997 1/20 0.50
TSHR P16473 2/20 0.47
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
POLB P06746 1/20 0.46
CYP2C19 P33261 1/20 0.46
KDM4E B2RXH2 1/20 0.46
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17469765 0.88 MAPK1 (0.51) ALDH1A1LMNAMAPK1HPGDTSHR
SCHEMBL7379444 0.85 TSHR (0.51) ALDH1A1LMNAMAPK1HPGDTSHR
SCHEMBL5101721 0.84 ALDH1A1 (0.53) ALDH1A1LMNAMAPK1HPGDTSHR
SCHEMBL1644885 0.84 MAPK1 (0.59) ALDH1A1LMNAMAPK1HPGDTSHR
SCHEMBL27778032 0.83 ALDH1A1 (0.49) ALDH1A1LMNAMAPK1HPGDIAPP
SCHEMBL7055476 0.83 ALDH1A1 (0.57) ALDH1A1LMNAMAPK1HPGDTSHR
SCHEMBL1405006 0.82 ALDH1A1 (0.51) ALDH1A1LMNAIAPPHTTPOLB
SCHEMBL11766148 0.82 ALDH1A1 (0.52) ALDH1A1LMNAMAPK1HPGDTSHR
SCHEMBL4190286 0.82 ALDH1A1 (0.52) ALDH1A1LMNAMAPK1HPGDTSHR
SCHEMBL8421119 0.82 ALDH1A1 (0.52) ALDH1A1LMNAMAPK1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150582-B2 Composition and method for neuropeptide S receptor (NPSR) antagonists RESEARCH TRIANGLE INSTITUTE (US) 2015-10-06 US disclosed
US-20150057268-A1 COMPOSITION AND METHOD FOR NEUROPEPTIDE S RECEPTOR (NPSR) ANTAGONISTS RESEARCH TRIANGLE INSTITUTE (US) 2015-02-26 US disclosed
EP-2079747-B1 HETEROCYCLIC COMPOUNDS USEFUL AS ANABOLIC AGENTS FOR LIVESTOCK ANIMALS PFIZER LTD (GB) 2011-03-09 EP disclosed
CN-101535315-A Heterocyclic compounds useful as anabolic agents for livestock animals PFIZER LTD (GB) 2009-09-16 CN disclosed
US-20080161288-A1 COMPOUNDS PFIZER INC. 2008-07-03 US disclosed
US-4659737-A Substituted aminomethyl benzopyrans having anti-hypertensive activities BAYER AKTIENGESELLSCHAFT (DE) 1987-04-21 US disclosed
US-4647579-A Circulation active novel substituted 4-hydroxy-benzopyrans BAYER AKTIENGESELLSCHAFT (DE) 1987-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150057268-A1 COMPOSITION AND METHOD FOR NEUROPEPTIDE S RECEPTOR (NPSR) ANTAGONISTS NPSR1, TACR1, NPFFR1 ALDH1A1 3727/4885LMNA 1925/4885MAPK1 3769/4885
US-20080161288-A1 COMPOUNDS ADRB2, ADRB1, ADRA2C ALDH1A1 295/4885LMNA 1543/4885MAPK1 2370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.